Udenfriend, Sidney
Hoffmann-La Roche Inc.,
United States
2025 Rank: 37921
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1495 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37921 | 45606 |
| Total Cites | 10094 | 10312 |
| H-index | 49 | 50 |
| Hm-index | 26 | 26 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 159 | 159 |
| Number of Single+First Authored Papers | 86 | 86 |
| Total Cites to Single+First Authored Papers | 2562 | 2573 |
| Number of Single+First+Last Authored Papers | 404 | 404 |
| Total Cites to Single+First+Last Authored Papers | 9458 | 9644 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8214 | 8274 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
2.11%
|
|
Udenfriend, Sidney
Hoffmann-La Roche Inc.,
United States
2024 Rank: 37265
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1548 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37265 | 45066 |
| Total Cites | 9681 | 9886 |
| H-index | 48 | 48 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 147 | 147 |
| Number of Single+First Authored Papers | 84 | 84 |
| Total Cites to Single+First Authored Papers | 2470 | 2481 |
| Number of Single+First+Last Authored Papers | 403 | 403 |
| Total Cites to Single+First+Last Authored Papers | 9080 | 9255 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7948 | 8016 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
2.07%
|
|
Udenfriend, Sidney
Hoffmann-La Roche Inc.,
United States
2023 Rank: 35323
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1533 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35323 | 42982 |
| Total Cites | 9435 | 9639 |
| H-index | 47 | 47 |
| Hm-index | 25 | 25 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 137 | 137 |
| Number of Single+First Authored Papers | 83 | 83 |
| Total Cites to Single+First Authored Papers | 2417 | 2428 |
| Number of Single+First+Last Authored Papers | 402 | 402 |
| Total Cites to Single+First+Last Authored Papers | 8845 | 9019 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7725 | 7792 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
2.12%
|
|
Udenfriend, Sidney
Hoffmann-La Roche Inc.,
United States
2022 Rank: 33344
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1521 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33344 | 40173 |
| Total Cites | 9146 | 9347 |
| H-index | 46 | 46 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 129 | 129 |
| Number of Single+First Authored Papers | 83 | 83 |
| Total Cites to Single+First Authored Papers | 2350 | 2361 |
| Number of Single+First+Last Authored Papers | 402 | 402 |
| Total Cites to Single+First+Last Authored Papers | 8580 | 8751 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7471 | 7535 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
2.15%
|
|
Udenfriend, Sidney
Hoffmann-La Roche Inc.,
United States
2021 Rank: 32047
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1458 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32047 | 38500 |
| Total Cites | 8934 | 9132 |
| H-index | 46 | 46 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 122 | 122 |
| Number of Single+First Authored Papers | 83 | 83 |
| Total Cites to Single+First Authored Papers | 2304 | 2315 |
| Number of Single+First+Last Authored Papers | 402 | 402 |
| Total Cites to Single+First+Last Authored Papers | 8385 | 8553 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7300 | 7364 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
2.17%
|
|
Udenfriend, Sidney
Hoffmann-La Roche Inc.,
United States
2020 Rank: 29514
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
None
Rank in SubField 1: 1165 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29514 | 35844 |
| Total Cites | 8650 | 8837 |
| H-index | 45 | 45 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 114 | 114 |
| Number of Single+First Authored Papers | 83 | 83 |
| Total Cites to Single+First Authored Papers | 2233 | 2244 |
| Number of Single+First+Last Authored Papers | 402 | 402 |
| Total Cites to Single+First+Last Authored Papers | 8120 | 8277 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7031 | 7093 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
2.12%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.